Delivering double digit growth for large drug makers is rare. KPMG's survey found that 93 percent of life sciences CEOs expect annual revenue growth ...
Delivered by KPMG Today (@KPMG_TO)
Article continues here
Follow @KPMG_TO on Twitter to get latest updates
